Lofta Home Sleep Test: Official Process, FDA Wording, and Evidence Limits

Official lofta.com pages describe a United States at-home sleep test path that includes a short telemedicine screening, a WatchPAT One device worn for one night, and interpretation by an independent board-certified sleep physician, with a prescription only if sleep apnea is diagnosed. Official pages do not agree on every FDA typographical form or on every displayed test price, and official FAQ text also states accuracy and eligibility limits. This guide records official Lofta wording as of November 18, 2026, distinguishes it from independent medical evidence, and does not diagnose, promise a cure, or invent FDA status.

Lofta Home Sleep Test: Official Process, FDA Wording, and Evidence Limits

Disclosure: This page may contain affiliate links. They do not influence our editorial conclusions. Read the disclosure.

Our pick

  1. Top pick

    Lofta

    Lofta is an official United States cash-pay sleep apnea company offering at-home sleep testing coordinated with independent physicians, CPAP equipment retail, a...

    See price at Lofta

Jump to the full guide

Lofta Home Sleep Test: Official Process, FDA Wording, and Evidence Limits

Official Lofta get-tested-at-home photography from lofta.com

Official lofta.com pages describe a United States cash-pay path from a home sleep test to a physician’s report, not a do-it-yourself diagnosis and not a promised cure. Official information text, last modified September 24, 2026, says Lofta coordinates an at-home test reviewed by independent board-certified sleep physicians, and that a prescription is issued if sleep apnea is diagnosed. Official wording also says Lofta does not itself diagnose or prescribe. Official process steps are a screening questionnaire and a short telemedicine video call, usually under five minutes, with an independent medical practice; shipment of a WatchPAT One device from ZOLL Itamar for one night at home, with data sent automatically; interpretation and a personalized Sleep Report by a board-certified sleep physician, with a free retest if the medical team requires one; then a treatment path the customer chooses, officially including CPAP, an oral appliance through Lofta’s network of licensed providers, or doctor-guided GLP-1 care through Lofta partners. This guide records official Lofta wording as of November 18, 2026. It is not a clinical evaluation, not medical advice, and not a device test. Follow official device instructions and the advice of a licensed clinician. This guide does not diagnose anyone, does not promise that a home test or CPAP will cure sleep apnea, and does not invent FDA or prescription applicability beyond official typographical wording and official process limits.

Official device wording, official FDA typography, and official price disagreements

Official information text describes the WatchPAT One as an FDA-cleared, Type 3 disposable home sleep test worn on the wrist with a finger probe and chest sensor, validated against in-lab polysomnography (PSG), and able to measure true sleep time, sleep stages, and central as well as obstructive events. Official Sleep Report wording includes true sleep time, Apnea-Hypopnea Index (AHI), Respiratory Disturbance Index (RDI), Oxygen Desaturation Index (ODI), pulse, snoring, body position, and sleep stage statistics. Official text also says results can be used to prescribe CPAP, oral appliance therapy, or GLP-1 care, and that Lofta offers variants for oral appliance therapy or eXciteOSA and a dedicated version for DOT-regulated drivers.

Official typographical FDA wording does not fully agree across official lofta.com pages. Official information text uses “FDA-cleared.” Official Home Sleep Test merchandising uses both “FDA Cleared Technology” and “The WatchPAT is an FDA and DOT approved portable sleep apnea diagnostic device,” plus official “FDA-approved WatchPAT One” sentences on official about and product-detail blocks. This guide quotes those official typographical forms as printed. It does not independently verify an FDA listing, does not choose one official adjective as a silent correction, and does not invent a broader official approval, clearance, or indication than official pages state.

Official price wording also disagrees on official pages reviewed for this batch. Official information text lists the Home Sleep Test at “$189 at time of writing,” including telemedicine screening, the device, physician interpretation, the Sleep Report, and a prescription if diagnosed. Official product-page merchandising displays $132.30 beside $189.00. Official later page wording also says “Just $149.” This guide records those official figures as official page wording on November 18, 2026 and does not merge them into one unofficial current price, and it does not present official sale merchandising as an offers module. Official scale wording of “85,000+ Tests Delivered” is official merchandising, not an independently audited clinical-trial enrollment figure in this reading.

Official FAQ limits that official marketing does not erase

Official Home Sleep Test FAQ wording is more cautious than official “highly accurate” merchandising on the same official site. Official FAQ text says at-home sleep tests like the one Lofta uses are capable of testing for obstructive sleep apnea and central sleep apnea, and that these tests are recommended only for people with symptoms that indicate moderate to severe obstructive sleep apnea. Official wording says people with a history of cardiorespiratory diseases, stroke, insomnia, or hypoventilation should do a sleep study in a lab and not conduct an at-home sleep test. Official FAQ wording also says the accuracy of home sleep apnea tests ranges widely, between 68% and 91%, depending on the type of device and whether the person is at high or low risk, and that the tests are significantly more accurate for people at higher risk. Official merchandising elsewhere says the WatchPAT One “provides highly accurate results comparable to traditional sleep lab studies.” Both official statements are official lofta.com text. This guide does not treat official marketing accuracy language as independent clinical evidence, and it does not treat official FAQ ranges as a diagnosis of any reader.

Official Lofta photography for CPAP and sleep apnea diagnosis merchandising

Official FAQ wording also says a sleep test, at home or in a lab, requires a prescription from a physician before it can be taken, and that a CPAP machine in the United States is a federally regulated medical device that requires a prescription. Official insurance wording says Lofta does not work with insurance companies, and that any reimbursement is at the insurer’s discretion; official text tells a customer who plans to submit the expense or results to consult the insurance company before purchasing. Official “if you really can’t sleep (less than 2.5 hours of sleep)” wording says a retest may be needed. Official SleepImage Ring merchandising describes a different official alternative device with official cardiopulmonary coupling language; this guide records that official product copy as official merchandising, not as an independently compared diagnostic standard.

Official scope limits remain in force around the official test path. Official text says Lofta serves the United States only, is not an emergency or urgent care service, and does not itself diagnose or prescribe. Official CPAP shipping, official RxExpress renewal limits, and official signature rules are recorded in the official prescription and shipping guide. Official 60-night returns and official mask-exchange disagreements are recorded in the official returns guide. Official company identity, cash-pay limits, and “who Lofta is not for” wording are recorded in the official about guide. Official LoftaCare coaching and company-reported compliance figures are recorded in the official LoftaCare guide.

Official test wording this guide will not stretch into medical proof

The official Lofta Home Sleep Test reading is official process language plus official disagreements and official limits. Official steps run from a short telemedicine screen to a one-night WatchPAT One test and an independent physician’s Sleep Report, with a prescription only if that physician diagnoses sleep apnea. Official FDA typography includes both “cleared” and “approved,” which this guide leaves visible. Official prices of $189, $132.30, and $149 are official page figures, not one unofficial corrected price. Official FAQ text limits who an official at-home test is recommended for, states an official 68% to 91% accuracy range for home tests as a class, and still requires official clinical judgment. This guide does not diagnose, does not promise a cure, and does not replace official device instructions or licensed medical advice.

Official screening, official retest, and official treatment choice after a report

Official screening wording is official clinical-process language, not a quiz that this guide can score for a reader. Official text describes an online health questionnaire and a short telemedicine video call, usually under five minutes, with an independent medical practice that reviews history and approves the home sleep test. Official telemedicine-detail wording says that, in some cases, co-morbidities, underlying conditions, or risk factors may be discussed, and that the content of the call is at the discretion of the healthcare professional. Official approval of a test is official physician-practice discretion. This guide does not tell any reader that they have, or do not have, sleep apnea. Official retest wording is official and limited. Official information text says a retest is free if the medical team requires one. Official FAQ wording says that if a person really cannot sleep, officially less than 2.5 hours, a retest may be needed. Official “even if your sleep feels bothered” wording says that, in most cases, the official device can get enough information for conclusive results. Those official sentences remain official Lofta FAQ and policy language. They are not unofficial permission to ignore official in-lab recommendations for people with official listed histories such as cardiorespiratory disease, stroke, insomnia, or hypoventilation. Official treatment-path wording after a Sleep Report is official choice language among official CPAP, official oral-appliance, and official doctor-guided GLP-1 partner care, depending on what the official physician and customer decide. Official “gold-standard therapy” language for CPAP is official merchandising on official test pages, not independent guideline text verified here, and not a promise that CPAP is appropriate or curative for every person. Official eXciteOSA and official SleepImage Ring merchandising remain official alternative or variant copy. Official prescription still depends on official physician judgment, and official CPAP shipment still depends on official prescription verification described in the official shipping guide. Official device use, if prescribed, should follow official instructions and licensed clinical advice.

References

Meet your guide

Lipeiguan

author